REFERENCES
- Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A. Functional
outcomes in elderly patients with hospitalized COVID-19 pneumonia: A
1 year follow-up study. Influenza and other respiratory viruses2022;16:1197-1198.
- Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, Ito J, et al.
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron
variant. Nature. 2022; 603: 700-705.
- Horita N, Fukumoto T. Global case fatality rate from COVID-19 has
decreased by 96.8% during 2.5 years of the pandemic. J Med
Virol. 2023; 95: e28231.
- Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR,
Soucy JR, Daneman N. Bacterial co-infection and secondary infection in
patients with COVID-19: a living rapid review and meta-analysis.Clin Microbiol Infect. 2020; 26: 1622-1629.
- Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with
COVID-19: a systematic review and meta-analysis. J Infect.2020;81:266-275.
- Moreno-García E, Puerta-Alcalde P, Letona L, et al. Bacterial
co-infection at hospital admission in patients with COVID-19.Int J Infect Dis. 2022;118:197–202.
- Kohno S, Imamura Y, Shindo Y, Seki M, Ishida T, Teramoto S, Kadota J,
Tomono, K, Watanabe A. Clinical practice guidelines for nursing- and
healthcare-associated pneumonia (NHCAP) [complete translation].Respir Investig . 2014;51:103-126.
- Mahoney FI, Barthel D. Functional evaluation: the Barthel Index.Maryland State Med J. 1965;14:56-61.
- Committee for The Japanese Respiratory Society guidelines for the
management of respiratory infections. Guidelines for the management of
community acquired pneumonia in adults, revised edition.Respirology 2006;11(Suppl 3): S79-133.